Sort
82,697 grants matching “vaccine development”
Pulmonary responses to Bioweapon Category A Pathogens
$2,848,175Julie A Lovchik · University Of New Mexico · P01 · FY2009 · AI
Indiana University Melvin and Bren Simon Comprehensive Cancer Center Support Grant
$2,845,630Kelvin P Lee · Indiana University Indianapolis · P30 · FY2024 · CA
Non-Human Primate Discovery Team
$2,845,297Norman L Letvin · Duke University · U19 · FY2007 · AI
Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG)
$2,844,792David S Stephens · Emory University · UM1 · FY2020 · AI
NHP MHC ALLELE DISCOVERY AND TYPING TECHNOLOGY DEVELOPMENT for transplantation studies
$2,843,761Daniel Geraghty · Fred Hutchinson Cancer Research Center · N01 · FY2016 · AI
Core D - Genomics
$2,841,208Alexander L Greninger · Emory University · U19 · FY2022 · AI
Immunobiology for Marrow Allografts for Leukemia
$2,840,400Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA
Mucosal Immunity, Vaccines and Microbiota Interplay in Humans and Animal
$2,840,320Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2012 · AI
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
$2,840,289Kenneth Mark Coggeshall · Oklahoma Medical Research Foundation · U19 · FY2011 · AI
B cell Response to Respiratory Viruses
$2,840,010Sarah Andrews · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Understanding Papillomavirus Virion Proteins and Vaccines
$2,839,931John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
MALARIA VACCINE PRODUCTION AND SUPPORT SERVICES
$2,839,380Kathleen Kootz · Science Applications International Corp · N01 · FY2009 · AI
Cellular Immunology Core Laboratory
$2,839,188Amitinder Kaur · Tulane University Of Louisiana · N01 · FY2024 · AI
Genetic and Biochemical Approaches to Tyrosine Kinase and Lymphocyte Signaling
$2,838,737Pamela Schwartzberg · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Leadership Group for a Global HIV Vaccine Clinical Trials Network
$2,838,119Lawrence Corey · Fred Hutchinson Cancer Research Center · U01 · FY2008 · AI
Defining signatures for immune responsiveness by functional systems immunology
$2,837,004David A. Hafler · Yale University · U19 · FY2012 · AI
Advanced Development of a Vaccine for Acute Flaccid Myelitis Associated with Enterovirus D68
$2,836,966Dinja Oosterhoff · Ministerie Van Volksgezondheid, Welzijn En Sport · N01 · FY2020 · AI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Prevention Trials Network
$2,835,895Deborah J Donnell · Fred Hutchinson Cancer Research Center · UM1 · FY2013 · AI
Laboratory And Preclinical Studies Of Dengue Viruses
$2,835,857Brian Murphy · Niaid Extramural Activities · Z01 · FY2007 · AI
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
$2,835,478Vaxine Pty Ltd · N01 · FY2018 · AI
Defining signatures for immune responsiveness by functional systems immunology
$2,834,344David A. Hafler · Yale University · U19 · FY2014 · AI
Supporting Informed Parental Decisions on HPV Vaccination through Safe and Personalized AI-Driven Conversations
$2,834,092Xiaoli Nan · Univ Of Maryland, College Park · R01 · FY2025 · CA
Correlates of protection against SIV/SHIV challenge
$2,832,697Hildegund C. J. Ertl · Wistar Institute · P01 · FY2009 · AI
Vaccine and Treatment Evaluation Units
$2,831,917Karen L. Kotloff · University Of Maryland Baltimore · N01 · FY2010 · AI
National AIDS Research Institute (NARI), Pune, INDIA: Clinical Trials Unit
$2,829,387Sanjay M Mehendale · National Aids Research Institute · U01 · FY2009 · AI